查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957881

2026年全球经皮给药系统市场报告

Transdermal Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，经皮给药系统的市场规模经历了显着成长。预计该市场规模将从2025年的400.1亿美元成长到2026年的430.9亿美元，复合年增长率（CAGR）为7.7%。过去几年成长要素包括口服药物的局限性、慢性病的普遍流行、提高患者用药依从性的需求、贴剂技术的进步以及医院对给药系统的日益普及。

预计未来几年，经皮给药系统的市场规模将强劲成长，2030年将达到579.4亿美元，复合年增长率（CAGR）为7.7%。预测期内的成长要素包括：自我给药疗法的普及、穿戴式医疗设备的广泛应用、慢性疾病负担的加重、药物递送技术的创新以及门诊服务的扩展。预测期内的关键趋势包括：含药贴片系统的日益普及、疼痛管理应用的扩展、对控释药物的需求、居家给药的成长以及微针技术的创新。

未来几年，慢性病盛行率的不断上升预计将推动经皮给药系统市场的成长。慢性病是指需要持续管理的长期健康状况，例如糖尿病和心臟病，这些疾病会限制日常生活。这些疾病的增加部分归因于久坐的生活方式，这种生活方式导致体力活动减少，进而造成体重增加、心血管风险上升和代谢失衡。经皮给药系统透过持续、可控制地经皮释放药物，在慢性病管理中发挥至关重要的作用，它能够提高患者的用药依从性，并维持稳定的治疗水平。例如，根据美国公共卫生研究机构健康指标与评估研究所 (IHME) 于 2023 年 6 月发布的报告，全球有超过 5 亿人患有糖尿病，预计到 2050 年，这一数字将翻一番以上，达到 13 亿人。因此，慢性病盛行率的上升趋势正在推动经皮给药系统市场的扩张。

经皮给药系统市场的主要企业正致力于微针技术等技术创新，以提高药物吸收率并增强患者依从性。微针技术是一种微创设备，可透过皮肤无痛给药，取代传统的注射方式。例如，韩国大宇製药有限公司于2024年10月发布了其微针平台「CLOPAM」。此技术可提高药物输送效率，减少注射带来的不适感，并达到可控制、持续的药物释放。其主要目标是提供一种无痛且稳定的给药方式，取代口服和注射药物，从而提高患者依从性和治疗效果。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球经皮给药系统市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术、循环经济
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 药物贴片系统的应用日益广泛
    • 疼痛管理应用的扩展
    • 对受管制药物释放的需求
    • 家庭药物配送的成长
    • 微针技术的创新

第五章 终端用户产业市场分析

  • 医院
  • 居家医疗
  • 製药公司
  • 研究机构
  • 专科诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球经皮给药系统市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球经皮给药系统市场规模、对比及成长率分析
  • 全球经皮给药系统市场表现：规模与成长，2020-2025年
  • 全球经皮给药系统市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 依配方类型
  • 药物贴片、储库型、基质型、微储库型
  • 透过技术
  • 离子导入、微孔化
  • 透过使用
  • 疼痛管理、中枢神经系统、心血管疾病、戒烟支持
  • 最终用户
  • 医院、居家医疗、製药公司、研究机构
  • 按类型细分：含药贴剂
  • 单层含药黏合剂，多层含药黏合剂
  • 按类型细分：储层类型
  • 凝胶储液系统、液体储液系统、固体储液系统
  • 按类型细分：矩阵类型
  • 聚合物基质系统、脂质基质系统、水凝胶基质系统
  • 按类型细分：微型储库类型
  • 微针阵列、微乳液储库、奈米颗粒注射储库

第十章 区域与国别分析

  • 全球经皮给药系统市场：依地区划分，历史资料及预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球经皮给药系统市场：依国家划分，历史资料及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 经皮给药系统市场：竞争格局及市场占有率（2024年）
  • 经皮给药系统市场：公司评估矩阵
  • 经皮给药系统市场：公司概况
    • Pfizer Inc.
    • Johnson & Johnson
    • Bayer AG
    • Novartis AG
    • 3M Company

第37章 其他大型企业和创新企业

  • Teva Pharmaceutical Industries Ltd., Mylan NV, Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年经皮给药系统市场：提供新机会的国家
  • 2030年经皮给药系统市场：充满新机会的细分市场
  • 2030年经皮给药系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH4MTDDS01_G26Q1

Transdermal drug delivery systems are methods of administering medication through the skin, allowing for controlled and continuous release of the drug into the bloodstream over time. These systems typically come in the form of a patch or similar device that adheres to the skin, gradually delivering medication while offering benefits such as bypassing the digestive system and maintaining consistent drug levels in the body.

The primary formulation types of transdermal drug delivery systems include drug-in-patch, reservoir type, matrix type, and microreservoir type. The drug-in-patch formulation is especially popular in the consumer health sector due to its convenience, notably for treatments like nicotine replacement and hormone therapy patches. Key technologies in transdermal delivery include iontophoresis and microporation. Applications span pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and these systems are utilized across hospitals, home healthcare, pharmaceutical companies, and research institutes.

Tariffs have influenced the transdermal drug delivery systems market by increasing the cost of imported active pharmaceutical ingredients, polymers, and electronic components used in advanced patches and iontophoresis devices, leading to higher manufacturing expenses and pricing pressures. The impact is most significant across drug-in-patch, reservoir, and microreservoir systems, with Asia-Pacific and North American regions being the most affected due to their dependence on cross-border pharmaceutical and medical device supply chains. However, tariffs are also encouraging pharmaceutical companies to localize production, strengthen domestic manufacturing, and invest in supply chain resilience, which is gradually improving regional self-sufficiency and long-term market stability.

The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including transdermal drug delivery systems industry global market size, regional shares, competitors with a transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $40.01 billion in 2025 to $43.09 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to oral drug limitations, chronic disease prevalence, patient compliance needs, patch technology development, hospital drug delivery usage.

The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $57.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to self-administered therapy growth, wearable healthcare devices, chronic disease burden, drug delivery innovation, outpatient care expansion. Major trends in the forecast period include growing adoption of drug-in-patch systems, expansion of pain management applications, demand for controlled drug release, growth of home-based drug delivery, innovation in microneedle technology.

The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the coming years. Chronic diseases are long-term health conditions that require ongoing management, such as diabetes or heart disease, and can limit daily activities. The rise in these diseases is partly due to more sedentary lifestyles, as reduced physical activity contributes to weight gain, poor cardiovascular health, and metabolic imbalances. Transdermal drug delivery systems play a key role in chronic disease management by providing continuous, controlled release of medication through the skin, improving patient adherence and maintaining stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to more than double to 1.3 billion by 2050. Consequently, the growing prevalence of chronic diseases is supporting the expansion of the transdermal drug delivery systems market.

Key companies in the transdermal drug delivery systems market are focusing on technological innovations, such as microneedle technology, to enhance drug absorption and improve patient compliance. Microneedle technologies are minimally invasive devices that deliver drugs painlessly through the skin, providing an alternative to traditional injections. For instance, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This technology improves drug delivery efficiency, reduces the discomfort associated with injections, and enables controlled, sustained release of medication. Its primary goal is to provide a painless, consistent alternative to oral or injectable medications, enhancing both patient adherence and treatment outcomes.

In August 2024, Insud Pharma S.L., a Spain-based global pharmaceutical company, acquired Agile Therapeutics Inc. for approximately $0.045 billion. This acquisition enables Insud Pharma to strengthen its women's health and transdermal drug delivery capabilities by integrating Agile's flagship product, Twirla, a transdermal contraceptive patch delivering levonorgestrel and ethinyl estradiol through the skin. Agile Therapeutics Inc., based in the US, specializes in women's healthcare and transdermal drug delivery technologies.

Major companies operating in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH, Cipla Ltd., Sun Pharmaceutical Industries Ltd., Luye Pharma Group, Mundipharma International Ltd., Aveva Drug Delivery Systems Ltd.

North America was the largest region in the transdermal drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transdermal drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Formulation Type: Drug-In-Patch; Reservoir Type; Matrix Type; Microreservoir Type
  • 2) By Technology: Iontophoresis; Microporation
  • 3) By Application: Pain Management; Central Nervous System; Cardiovascular Diseases; Smoking Cessation
  • 4) By End User: Hospitals; Home Healthcare; Pharmaceutical Companies; Research Institutes
  • Subsegments:
  • 1) By Drug-In-Patch: Single-layer Drug-in-Adhesive; Multi-layer Drug-in-Adhesive
  • 2) By Reservoir Type: Gel Reservoir Systems; Liquid Reservoir Systems; Solid Reservoir Systems
  • 3) By Matrix Type: Polymer Matrix Systems; Lipid Matrix Systems; Hydrogel Matrix Systems
  • 4) By Microreservoir Type: Microneedle Arrays; Microemulsion Reservoirs; Nanoparticle-Infused Reservoirs
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; Novartis AG; 3M Company; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Skyepharma PLC; Noven Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co. Inc.; Watson Pharmaceuticals Inc.; Endo International plc; Transdermal Technologies Inc.; Actavis Inc.; LTS Lohmann Therapie-Systeme AG; Perrigo Company plc; Nitto Denko Corporation; Zydus Lifesciences Ltd.; Dr. Reddy's Laboratories Ltd.; Sandoz International GmbH; Cipla Ltd.; Sun Pharmaceutical Industries Ltd.; Luye Pharma Group; Mundipharma International Ltd.; Aveva Drug Delivery Systems Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Transdermal Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Transdermal Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Transdermal Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Transdermal Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Drug-In-Patch Systems
    • 4.2.2 Expansion Of Pain Management Applications
    • 4.2.3 Demand For Controlled Drug Release
    • 4.2.4 Growth Of Home-Based Drug Delivery
    • 4.2.5 Innovation In Microneedle Technology

5. Transdermal Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Home Healthcare
  • 5.3 Pharmaceutical Companies
  • 5.4 Research Institutes
  • 5.5 Specialty Clinics

6. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Transdermal Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Transdermal Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Transdermal Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Transdermal Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Transdermal Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Transdermal Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Transdermal Drug Delivery Systems Market Segmentation

  • 9.1. Global Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-In-Patch, Reservoir Type, Matrix Type, Microreservoir Type
  • 9.2. Global Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Iontophoresis, Microporation
  • 9.3. Global Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pain Management, Central Nervous System, Cardiovascular Diseases, Smoking Cessation
  • 9.4. Global Transdermal Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Home Healthcare, Pharmaceutical Companies, Research Institutes
  • 9.5. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Drug-In-Patch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive
  • 9.6. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Reservoir Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gel Reservoir Systems, Liquid Reservoir Systems, Solid Reservoir Systems
  • 9.7. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Matrix Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymer Matrix Systems, Lipid Matrix Systems, Hydrogel Matrix Systems
  • 9.8. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Microreservoir Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microneedle Arrays, Microemulsion Reservoirs, Nanoparticle-Infused Reservoirs

10. Transdermal Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Transdermal Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Transdermal Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Transdermal Drug Delivery Systems Market

  • 11.1. Asia-Pacific Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Transdermal Drug Delivery Systems Market

  • 12.1. China Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Transdermal Drug Delivery Systems Market

  • 13.1. India Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Transdermal Drug Delivery Systems Market

  • 14.1. Japan Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Transdermal Drug Delivery Systems Market

  • 15.1. Australia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Transdermal Drug Delivery Systems Market

  • 16.1. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Transdermal Drug Delivery Systems Market

  • 17.1. South Korea Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Transdermal Drug Delivery Systems Market

  • 18.1. Taiwan Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Transdermal Drug Delivery Systems Market

  • 19.1. South East Asia Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Transdermal Drug Delivery Systems Market

  • 20.1. Western Europe Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Transdermal Drug Delivery Systems Market

  • 21.1. UK Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Transdermal Drug Delivery Systems Market

  • 22.1. Germany Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Transdermal Drug Delivery Systems Market

  • 23.1. France Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Transdermal Drug Delivery Systems Market

  • 24.1. Italy Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Transdermal Drug Delivery Systems Market

  • 25.1. Spain Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Transdermal Drug Delivery Systems Market

  • 26.1. Eastern Europe Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Transdermal Drug Delivery Systems Market

  • 27.1. Russia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Transdermal Drug Delivery Systems Market

  • 28.1. North America Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Transdermal Drug Delivery Systems Market

  • 29.1. USA Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Transdermal Drug Delivery Systems Market

  • 30.1. Canada Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Transdermal Drug Delivery Systems Market

  • 31.1. South America Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Transdermal Drug Delivery Systems Market

  • 32.1. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Transdermal Drug Delivery Systems Market

  • 33.1. Middle East Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Transdermal Drug Delivery Systems Market

  • 34.1. Africa Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Transdermal Drug Delivery Systems Market Regulatory and Investment Landscape

36. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Transdermal Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Transdermal Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Transdermal Drug Delivery Systems Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

37. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies

  • Teva Pharmaceutical Industries Ltd., Mylan N.V., Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH

38. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market

40. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Transdermal Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Transdermal Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Transdermal Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer